Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Olive Leaf Extract Attenuates Inflammatory Activation and DNA Damage in Human Arterial Endothelial Cells.

Burja B, Kuret T, Janko T, Topalović D, Živković L, Mrak-Poljšak K, Spremo-Potparević B, Žigon P, Distler O, Čučnik S, Sodin-Semrl S, Lakota K, Frank-Bertoncelj M.

Front Cardiovasc Med. 2019 May 16;6:56. doi: 10.3389/fcvm.2019.00056. eCollection 2019.

2.

Interpreting the MicroRNA-15/107 family: interaction identification by combining network based and experiment supported approach.

Wang S, Zhu W, Xu J, Guo Y, Yan J, Meng L, Jiang C, Lu S.

BMC Med Genet. 2019 May 31;20(1):96. doi: 10.1186/s12881-019-0824-9.

3.

Induced androgenetic development in rainbow trout and transcriptome analysis of irradiated eggs.

Ocalewicz K, Gurgul A, Pawlina-Tyszko K, Szmatoła T, Jasielczuk I, Bugno-Poniewierska M, Dobosz S.

Sci Rep. 2019 May 30;9(1):8084. doi: 10.1038/s41598-019-44568-7.

4.

Expression of disease-related miRNAs in white-matter lesions of progressive multiple sclerosis brains.

Tripathi A, Volsko C, Datta U, Regev K, Dutta R.

Ann Clin Transl Neurol. 2019 Mar 21;6(5):854-862. doi: 10.1002/acn3.750. eCollection 2019 May.

5.

Differential microRNA profile underlies the divergent healing responses in skin and oral mucosal wounds.

Simões A, Chen L, Chen Z, Zhao Y, Gao S, Marucha PT, Dai Y, DiPietro LA, Zhou X.

Sci Rep. 2019 May 9;9(1):7160. doi: 10.1038/s41598-019-43682-w.

6.

Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling.

Di Benedetto P, Panzera N, Cipriani P, Mastroiaco V, Tessitore A, Liakouli V, Ruscitti P, Berardicurti O, Carubbi F, Guggino G, Bianchi A, Di Marco A, Ciccia F, Alesse E, Giacomelli R.

Sci Rep. 2019 May 9;9(1):7144. doi: 10.1038/s41598-019-43638-0.

7.

MicroRNA profiling of mouse liver in response to DENV-1 infection by deep sequencing.

Pong LY, Parkkinen S, Dhanoa A, Gan HM, Wickremesinghe IAC, Syed Hassan S.

PeerJ. 2019 Apr 22;7:e6697. doi: 10.7717/peerj.6697. eCollection 2019.

8.

Deregulated MicroRNA Signature Following Glioblastoma Irradiation.

Toraih EA, El-Wazir A, Abdallah HY, Tantawy MA, Fawzy MS.

Cancer Control. 2019 Jan-Dec;26(1):1073274819847226. doi: 10.1177/1073274819847226.

9.

Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma.

Zhou Y, Zhang Q, Du M, Xiong D, Wang Y, Mohammed A, Lubet RA, Wang L, You M.

Cancers (Basel). 2019 Apr 4;11(4). pii: E477. doi: 10.3390/cancers11040477.

10.

DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions.

Poma AM, Condello V, Denaro M, Torregrossa L, Elisei R, Vitti P, Basolo F.

Oncotarget. 2019 Mar 5;10(19):1785-1797. doi: 10.18632/oncotarget.26639. eCollection 2019 Mar 5.

11.

A Multi-Cohort and Multi-Omics Meta-Analysis Framework to Identify Network-Based Gene Signatures.

Shafi A, Nguyen T, Peyvandipour A, Nguyen H, Draghici S.

Front Genet. 2019 Mar 19;10:159. doi: 10.3389/fgene.2019.00159. eCollection 2019.

12.

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors.

Tormo E, Ballester S, Adam-Artigues A, Burgués O, Alonso E, Bermejo B, Menéndez S, Zazo S, Madoz-Gúrpide J, Rovira A, Albanell J, Rojo F, Lluch A, Eroles P.

Sci Rep. 2019 Mar 29;9(1):5316. doi: 10.1038/s41598-019-41472-y.

13.

Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton.

Adamo A, Brandi J, Caligola S, Delfino P, Bazzoni R, Carusone R, Cecconi D, Giugno R, Manfredi M, Robotti E, Marengo E, Bassi G, Takam Kamga P, Dal Collo G, Gatti A, Mercuri A, Arigoni M, Olivero M, Calogero RA, Krampera M.

Front Immunol. 2019 Mar 12;10:446. doi: 10.3389/fimmu.2019.00446. eCollection 2019.

14.

Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments.

Iannolo G, Sciuto MR, Cuscino N, Pallini R, Douradinha B, Vitiani LR, De Maria R, Conaldi PG.

Cell Death Dis. 2019 Mar 19;10(4):263. doi: 10.1038/s41419-019-1499-z.

15.

Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach.

Platania CBM, Maisto R, Trotta MC, D'Amico M, Rossi S, Gesualdo C, D'Amico G, Balta C, Herman H, Hermenean A, Ferraraccio F, Panarese I, Drago F, Bucolo C.

Br J Pharmacol. 2019 Jul;176(13):2179-2194. doi: 10.1111/bph.14665. Epub 2019 May 9.

PMID:
30883703
16.

Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.

Navarro A, Moises J, Santasusagna S, Marrades RM, Viñolas N, Castellano JJ, Canals J, Muñoz C, Ramírez J, Molins L, Monzo M.

BMC Pulm Med. 2019 Feb 28;19(1):55. doi: 10.1186/s12890-019-0816-8.

17.

Prognostic significance of deregulated microRNAs in uveal melanomas.

Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M, Candido S.

Mol Med Rep. 2019 Apr;19(4):2599-2610. doi: 10.3892/mmr.2019.9949. Epub 2019 Feb 11.

18.

Deep sequencing reveals two Jurkat subpopulations with distinct miRNA profiles during camptothecin-induced apoptosis.

Erdoğan İ, Coşacak Mİ, Nalbant A, Akgül B.

Turk J Biol. 2018 Apr 27;42(2):113-122. doi: 10.3906/biy-1710-62. eCollection 2018.

19.

hsa-miR-301a- and SOX10-dependent miRNA-TF-mRNA regulatory circuits in breast cancer.

Öztemur Islakoğlu Y, Noyan S, Gür Dedeoğlu B.

Turk J Biol. 2018 Apr 27;42(2):103-112. doi: 10.3906/biy-1708-17. eCollection 2018.

20.

MRI phenotypes in MS: Longitudinal changes and miRNA signatures.

Hemond CC, Healy BC, Tauhid S, Mazzola MA, Quintana FJ, Gandhi R, Weiner HL, Bakshi R.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 14;6(2):e530. doi: 10.1212/NXI.0000000000000530. eCollection 2019 Mar.

Supplemental Content

Support Center